Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Review ArticleCONTINUING EDUCATION

Radioiodine Scintigraphy with SPECT/CT: An Important Diagnostic Tool for Thyroid Cancer Staging and Risk Stratification

Anca M. Avram
Journal of Nuclear Medicine Technology September 2014, 42 (3) 170-180; DOI: https://doi.org/10.2967/jnumed.111.104133
Anca M. Avram
Division of Nuclear Medicine/Radiology, University of Michigan Medical Center, Ann Arbor, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 3 170-180
DOI 
https://doi.org/10.2967/jnumed.111.104133
PubMed 
25190758

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication February 9, 2012
  • Accepted for publication March 27, 2012
  • Published online September 4, 2014.

Copyright & Usage 
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Anca M. Avram
  1. Division of Nuclear Medicine/Radiology, University of Michigan Medical Center, Ann Arbor, Michigan
  1. For correspondence or reprints contact: Anca M. Avram, Division of Nuclear Medicine/Radiology, University of Michigan Medical Center, B1G 505G University Hospital, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-5028. E-mail: ancaa{at}umich.edu
View Full Text

Statistics from Altmetric.com

Cited By...

  • 82 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • American Thyroid Association Statement on Preoperative Imaging for Thyroid Cancer Surgery
    Michael W. Yeh, Andrew J. Bauer, Victor A. Bernet, Robert L. Ferris, Laurie A. Loevner, Susan J. Mandel, Lisa A. Orloff, Gregory W. Randolph, David L. Steward
    Thyroid 2015 25 1
  • Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomas
    Lingzhou Zhao, Jingyi Zhu, Yongjun Cheng, Zhijuan Xiong, Yueqin Tang, Lilei Guo, Xiangyang Shi, Jinhua Zhao
    ACS Applied Materials & Interfaces 2015 7 35
  • 99mTc-Labeled Multifunctional Low-Generation Dendrimer-Entrapped Gold Nanoparticles for Targeted SPECT/CT Dual-Mode Imaging of Tumors
    Xin Li, Zuogang Xiong, Xiaoying Xu, Yu Luo, Chen Peng, Mingwu Shen, Xiangyang Shi
    ACS Applied Materials & Interfaces 2016 8 31
  • Preablation 131-I Scans With SPECT/CT in Postoperative Thyroid Cancer Patients: What Is the Impact on Staging?
    Anca M. Avram, Lorraine M. Fig, Kirk A. Frey, Milton D. Gross, Ka Kit Wong
    The Journal of Clinical Endocrinology & Metabolism 2013 98 3
  • Personalized management of differentiated thyroid cancer in real life – practical guidance from a multidisciplinary panel of experts
    Alfredo Campennì, Daniele Barbaro, Marco Guzzo, Francesca Capoccetti, Luca Giovanella
    Endocrine 2020 70 2
  • Value of 131I SPECT/CT for the evaluation of differentiated thyroid cancer: a systematic review of the literature
    Yan-Li Xue, Zhong-Ling Qiu, Hong-Jun Song, Quan-Yong Luo
    European Journal of Nuclear Medicine and Molecular Imaging 2013 40 5
  • Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy
    Augusto Enrique Llamas-Olier, Diana Isabel Cuéllar, Giancarlo Buitrago
    Thyroid 2018 28 10
  • Clinical applications of SPECT/CT after first I‐131 ablation in patients with differentiated thyroid cancer
    Shin Young Jeong, Sang‐Woo Lee, Hae Won Kim, Bong‐Il Song, Byeong‐Cheol Ahn, Jaetae Lee
    Clinical Endocrinology 2014 81 3
  • Emerging technologies for image guidance and device navigation in interventional radiology
    George C. Kagadis, Konstantinos Katsanos, Dimitris Karnabatidis, George Loudos, George C. Nikiforidis, William R. Hendee
    Medical Physics 2012 39 9
  • 124I PET/CT in the pretherapeutic staging of differentiated thyroid carcinoma: comparison with posttherapy 131I SPECT/CT
    Cecile de Pont, Servais Halders, Jan Bucerius, Felix Mottaghy, Boudewijn Brans
    European Journal of Nuclear Medicine and Molecular Imaging 2013 40 5

Article usage

Article usage: August 2014 to April 2025

AbstractFullPdf
Aug 2014300
Sep 201450387118
Oct 20143845899
Nov 20142763274
Dec 20143152545
Jan 201514912138
Feb 20151353736
Mar 20151231228
Apr 20151191331
May 20151212134
Jun 20151293536
Jul 20151322541
Aug 20151403137
Sep 20151171634
Oct 20151283664
Nov 2015952337
Dec 20151192735
Jan 20161893242
Feb 2016872942
Mar 20161372445
Apr 20161393520
May 20161354330
Jun 20161404532
Jul 2016835033
Aug 20161012031
Sep 2016835334
Oct 2016492518
Nov 201639297
Dec 201616213928
Jan 2017854825
Feb 2017595019
Mar 2017452417
Apr 2017711215
May 2017342035
Jun 2017371913
Jul 2017351227
Aug 201769834
Sep 2017742625
Oct 2017761929
Nov 2017762418
Dec 2017361115
Jan 2018432015
Feb 2018652618
Mar 2018482714
Apr 2018702815
May 2018531240
Jun 2018351317
Jul 2018451216
Aug 2018491115
Sep 2018361216
Oct 2018543722
Nov 2018231422
Dec 201839917
Jan 2019421924
Feb 2019321322
Mar 2019371218
Apr 201938920
May 2019252518
Jun 2019871234
Jul 2019282032
Aug 2019321446
Sep 2019411443
Oct 2019564339
Nov 2019424731
Dec 2019351728
Jan 2020252128
Feb 2020472124
Mar 2020432928
Apr 2020312012
May 2020642922
Jun 2020881817
Jul 2020701811
Aug 202085515
Sep 202088519
Oct 20201041723
Nov 20201142424
Dec 20201125927
Jan 2021108726
Feb 2021124638
Mar 202195022
Apr 202176539
May 202156126
Jun 2021135023
Jul 2021177325
Aug 2021175533
Sep 2021157934
Oct 2021208962
Nov 2021188152
Dec 202185335
Jan 2022147538
Feb 2022104924
Mar 2022209248
Apr 2022189535
May 2022257574
Jun 202266518
Jul 202294423
Aug 202264925
Sep 2022810024
Oct 20221411038
Nov 2022812025
Dec 2022179535
Jan 2023118532
Feb 20231211640
Mar 20231512335
Apr 2023159734
May 20231211833
Jun 20231412032
Jul 2023119036
Aug 2023148243
Sep 2023149441
Oct 2023189825
Nov 20232415835
Dec 20232320372
Jan 202429141527
Feb 20242012233
Mar 20246915275
Apr 2024139044
May 20241211440
Jun 2024812118
Jul 2024816733
Aug 2024139424
Sep 20241510722
Oct 20241712636
Nov 20242113121
Dec 2024817826
Jan 20251013531
Feb 20251315727
Mar 20251415949
Apr 20251724658
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 42 (3)
Journal of Nuclear Medicine Technology
Vol. 42, Issue 3
September 1, 2014
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Radioiodine Scintigraphy with SPECT/CT: An Important Diagnostic Tool for Thyroid Cancer Staging and Risk Stratification
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Radioiodine Scintigraphy with SPECT/CT: An Important Diagnostic Tool for Thyroid Cancer Staging and Risk Stratification
Anca M. Avram
Journal of Nuclear Medicine Technology Sep 2014, 42 (3) 170-180; DOI: 10.2967/jnumed.111.104133

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Radioiodine Scintigraphy with SPECT/CT: An Important Diagnostic Tool for Thyroid Cancer Staging and Risk Stratification
Anca M. Avram
Journal of Nuclear Medicine Technology Sep 2014, 42 (3) 170-180; DOI: 10.2967/jnumed.111.104133
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • ADVANTAGES, DISADVANTAGES, AND LIMITATIONS OF SPECT/CT
    • UTILITY OF POST-THERAPY RADIOIODINE SPECT/CT
    • UTILITY OF SPECT/CT FOR PROBLEM SOLVING (EVALUATION OF UNUSUAL RADIOACTIVITY DISTRIBUTIONS)
    • UTILITY OF DIAGNOSTIC PREABLATION RADIOIODINE SPECT/CT
    • UTILITY OF RADIOIODINE SPECT/CT FOR LESIONAL DOSIMETRY
    • WHEN TO USE SPECT/CT FOR BEST IMPACT IN THYROID CANCER MANAGEMENT
    • CONCLUSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • I-131 Postablation SPECT/CT Predicts Relapse of Papillary Thyroid Carcinoma more Accurately than Whole Body Scan
  • A Parallel-Cone Collimator for High-Energy SPECT
  • Google Scholar

More in this TOC Section

  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • PET/CT Case Series: Unmasking the Mystery of Cardiac Sarcoidosis
  • Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure
Show more Continuing Education

Similar Articles

Keywords

  • radioiodine fusion imaging
  • thyroid cancer
  • thyroid cancer staging and risk stratification
SNMMI

© 2025 SNMMI

Powered by HighWire